Results 101 to 110 of about 10,389 (214)
Neurosteroids are pleiotropic molecules involved in various neurodegenerative diseases with neuroinflammation. We assessed neurosteroids’ serum levels in a cohort of Parkinson’s Disease (PD) patients with heterozygous glucocerebrosidase (GBA) mutations ...
Francesco Cavallieri +10 more
doaj +1 more source
The kinetics of glucocerebrosidase synthesis and degradation in rat peritoneal macrophages and in human fibroblasts have been studied using conduritol B epoxide (CBE), an irreversible and specific inhibitor of mammalian glucocerebrosidase.
Das, Pijush K. +2 more
core +1 more source
Gaucher disease (GD) is a rare genetic metabolic disorder characterized by a dysfunction of the lysosomal glycoside hydrolase glucocerebrosidase (GCase) due to mutations in the gene GBA1, leading to the cellular accumulation of glucosylceramide (GlcCer).
Costanza Ceni +10 more
doaj +1 more source
Galactosylated and mannosylated liposomes were more efficient in transporting liposome-entrapped β-glucocerebrosidase to liver compared to nonglycosylated liposomes.
Zirzow, Gregory C. +4 more
core +1 more source
Knowledge of the cellular distribution and subcellular localization of mannose-terminal glucocerebrosidase after intravenous infusion is necessary for understanding the efficacy of targeted enzyme replacement therapy for Gaucher's disease.
F S Jin, G J Murray
core +1 more source
Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers
Glucocerebrosidase (GBA) gene mutations represent a strong risk factor for Parkinson disease (PD). PD penetrance in GBA mutation carriers, which represents a key issue for genetic counseling, especially for relatives of patients with Gaucher disease (GD),
Condroyer, C +19 more
core +1 more source
Case Report: Novel treatment approach for severe interstitial lung disease in type 3 Gaucher disease
Gaucher Disease Type 3 (GD3) is a rare lysosomal storage disorder characterized by both visceral and neurological involvement. Pulmonary manifestations can significantly impact prognosis and quality of life.
Vincenza Gragnaniello +7 more
doaj +1 more source
Gaucher disease (GD) is a lysosomal storage disorder caused by a deficiency in the GBA1‐encoded enzyme, β‐glucocerebrosidase. Enzyme replacement therapy is ineffective for neuronopathic Gaucher disease (nGD).
Kanako Higashi +28 more
doaj +1 more source
본 발명은 GBA(β-glucocerebrosidase) 단백질을 포함하는 엑소솜(GBA:EXPLOR)을 대량으로 제조하는 방법, 상기 엑소솜 제조에 사용될 수 있는 엑소솜 제조용 벡터, 상기 방법으로 제조된 GBA(β-glucocerebrosidase) 단백질을 포함하는 엑소솜 및 이를 유효성분으로 함유하는 고셔병 치료용 약학적 조성물에 관한 것이다.
류승욱 +4 more
core +1 more source
Glucocerebrosidase mutations in diffuse Lewy body disease
Clinicogenetic and pathological studies have shown that mutations of the glucocerebrosidase gene (GBA) are a risk factor for Parkinson's disease and Lewy body disorders.
Alex Rajput +46 more
core +1 more source

